logo

UCRD

VictoryShares Corporate Bond ETF·NASDAQ
--
--(--)
--
--(--)
VictoryShares Corporate Bond ETF Fundamentals
Assets Under Management
149.92MUSD
Fund Flows (1Y)
10.83MUSD
Dividend Yield (TTM)
4.25%
Discount/Premium to NAV
0.19%
Shares Outstanding
7.00M
Expense Ratio
0.40%
Returns
1-Month
3-Month
YTD
1-Year
3-Year
5-Year
Price Performance
-2.29%-1.38%-1.11%+1.06%+3.04%-14.32%
NAV Total Return
-2.13%-0.77%-0.54%+5.22%+16.14%-0.04%
Ratings

Aime Ratings

No data is currently available

No data is currently available

Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis

Top 10 Holdings

Symbol

Ratio

logo

MORGAN ST VRN 05/04/27

1.31%
logo

BANK OF VRN 04/22/32

1.07%
logo

AT&T INC 3.1% 02/01/43

0.96%
logo

BANK OF A VRN 12/20/28

0.83%
logo

US T-BOND 4.125% 08/15/53

0.79%
logo

LLOYDS B VRN 05/11/27

0.67%
logo

NATWEST G VRN 06/14/27

0.67%
logo

US T-BOND 4.75% 08/15/55

0.65%
logo

HSBC HOLD VRN 08/17/29

0.64%
logo

TRUIST FIN VRN 06/07/29

0.64%

Top 10 Weight 8.23%

473 Total Holdings

Is SPY better than UCRD?
Dividends

Dividend Payout History

Ex-Div Date
Record Date
Payment Date
Amount
2026-03-102026-03-102026-03-110.075
2026-02-092026-02-092026-02-100.071
2026-01-082026-01-082026-01-090.019
2025-12-112025-12-112025-12-120.128
2025-11-072025-11-072025-11-100.068
2025-10-092025-10-092025-10-100.080
2025-09-082025-09-082025-09-090.094

Show more

How Much Does UCRD Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy UCRD?
Fund Flows